Moderna
MRNA
#1182
Rank
HK$120.76 B
Marketcap
HK$313.83
Share price
0.40%
Change (1 day)
-58.70%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Operating Margin for Moderna (MRNA)

Operating Margin as of December 2024 (TTM): -46.06%

According to Moderna 's latest financial reports and stock price the company's current Operating Margin is -46.06%. At the end of 2023 the company had an Operating Margin of -58.37%.

Operating Margin history for Moderna from 2018 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-58.37%-215.05%
202250.73%-32.28%
202174.90%-127.59%
2020-271.53%-74.69%
2019-1,072.92%241.94%
2018-313.77%116.92%
2017-144.65%-31.74%
2016-211.91%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-118.00% 156.19%๐Ÿ‡บ๐Ÿ‡ธ USA
3.14%-106.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,576.98% 3,323.75%๐Ÿ‡บ๐Ÿ‡ธ USA
-23.71%-48.52%๐Ÿ‡บ๐Ÿ‡ธ USA
25.49%-155.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-85.77% 86.21%๐Ÿ‡บ๐Ÿ‡ธ USA
17.68%-138.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-61.01% 32.45%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.